Tobramycin Assay
Private Tobramycin Assay testing in London for £280, measuring one antibiotic level with results expected in around 3 days.
Turnaround time
3 business days
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the Tobramycin Assay Test
The Tobramycin Assay measures the concentration of the aminoglycoside antibiotic Tobramycin in the blood, supporting therapeutic drug monitoring where this medicine is being used.
The test assesses 1 specialist drug-monitoring marker: Tobramycin Assay (Provide Clinical Details).
Tobramycin is an aminoglycoside antibiotic used to treat selected serious bacterial infections, particularly infections caused by susceptible Gram-negative organisms.
It can also be used in specific respiratory treatment pathways, including selected people with cystic fibrosis or chronic bacterial airway infection.
Aminoglycosides have a relatively narrow therapeutic window.
Concentrations need to be high enough to achieve effective antimicrobial activity but not so high or prolonged that toxicity becomes unnecessarily likely.
Two important potential adverse effects are nephrotoxicity, affecting the kidneys, and ototoxicity, affecting hearing or balance.
Therapeutic drug monitoring is therefore commonly used with systemic Tobramycin treatment.
The clinical meaning of the result depends heavily on when the blood sample was taken in relation to the dose.
Depending on the dosing regimen, clinicians may request a trough concentration, a peak concentration or another specifically timed level.
The dose, route, time of administration and exact sample time should therefore be documented.
Kidney function is also critical because Tobramycin is eliminated predominantly through the kidneys.
Reduced renal clearance can cause drug accumulation and increase toxicity risk.
The result should be interpreted by the clinical team prescribing the antibiotic rather than using a generic concentration range without reference to the dosing protocol.
What Does the Tobramycin Assay Test Check?
The test measures Tobramycin concentration in the blood to support safe and effective therapeutic drug monitoring. This test measures 1 specialist biomarker.
Tobramycin Assay (Provide Clinical Details)
Measures circulating Tobramycin concentration, supporting dose optimisation and assessment of potential drug accumulation when interpreted according to dose timing and kidney function.
Who May Benefit From the Tobramycin Assay Test?
Tobramycin monitoring is relevant to people currently receiving the antibiotic under clinical supervision.
People receiving intravenous or systemic Tobramycin - Drug-level monitoring can help maintain appropriate exposure.
People receiving repeated Tobramycin doses - Accumulation can occur when clearance is reduced.
People with reduced kidney function - Renal impairment can prolong Tobramycin elimination and increase toxicity risk.
People whose Tobramycin dose has recently changed - Repeat measurement can help assess the new dosing regimen.
People receiving prolonged aminoglycoside treatment - Longer treatment can increase the importance of toxicity monitoring.
People with unexpected changes in Creatinine or eGFR - Kidney deterioration can affect drug clearance.
People with a previous high Tobramycin concentration - Repeat testing can help determine whether the level has returned to the intended range.
People specifically instructed to have a timed peak or trough level - Accurate dose and sample timing is essential.
How to Prepare
The test cannot be interpreted reliably without accurate dosing and sampling times.
Do not independently delay or change an antibiotic dose to alter the result unless the prescribing clinical team has provided specific instructions.
Symptoms and Reasons to Consider the Tobramycin Assay Test
Tobramycin blood levels are usually measured because of the treatment regimen rather than symptoms alone.
A scheduled therapeutic drug-monitoring level - Tobramycin concentrations may be monitored routinely during treatment.
A rise in Creatinine while receiving Tobramycin - Reduced kidney function can increase drug accumulation.
New hearing changes - Aminoglycosides can cause ototoxicity and new hearing symptoms require clinical review.
Tinnitus or ringing in the ears - This can occur with ototoxicity and should be reported promptly.
New balance disturbance or vertigo - Vestibular toxicity is another potential aminoglycoside adverse effect.
An unexpectedly high previous drug level - Repeat testing may be needed before further dosing.
A change in renal function or fluid status - Pharmacokinetics can change substantially during acute illness.
Dose adjustment during treatment - Repeat levels can help assess whether exposure is appropriate after a change.
Tobramycin monitoring should be managed by the clinical team prescribing the antibiotic.
Do not alter or omit a dose solely because of a laboratory result without medical instructions.
New hearing loss, severe dizziness or rapidly worsening kidney function while taking Tobramycin requires prompt clinical review.
How to Book Your Tobramycin Assay Test
The Tobramycin Assay can be booked privately for clinician-directed therapeutic drug monitoring.
Choose the Tobramycin Assay
Select the individual Tobramycin drug-level test and provide the requested clinical details.
Select your sample collection option
Arrange blood collection at a location and time compatible with the prescribed monitoring protocol.
Attend your appointment
A trained healthcare professional collects the venous blood sample at the required interval from your Tobramycin dose.
Laboratory analysis
Your specimen undergoes quantitative measurement of Tobramycin Assay (Provide Clinical Details).
Receive your results securely
Your authorised result is delivered securely and should be reviewed by the clinician responsible for your antibiotic treatment.
When Will I Receive My Results?
The current London Blood Tests catalogue lists the Tobramycin Assay at £280.
The specialist laboratory turnaround is approximately 3 days after laboratory receipt.
The assay requires clinical dosing information and specialist therapeutic-drug analysis.
The sample undergoes measurement, quality-control procedures and result authorisation.
Where urgent Tobramycin monitoring is clinically required during inpatient treatment, hospital laboratories may use substantially faster pathways than routine private outpatient testing.
Understanding Your Results
Tobramycin results cannot be interpreted meaningfully without knowing the dosing regimen and exact sample time.
A higher-than-intended concentration can indicate excessive drug exposure or delayed clearance.
Reduced kidney function is one important reason Tobramycin can accumulate.
Dose adjustment or a change in dosing interval may be required, but this decision belongs to the treating clinical team.
A lower-than-intended concentration can potentially indicate inadequate drug exposure depending on when the sample was taken and the treatment protocol.
Peak and trough targets differ because they assess different points in the drug concentration curve.
Modern once-daily aminoglycoside dosing protocols can also use other timed concentrations and pharmacokinetic calculations.
The laboratory's value should therefore always be interpreted using the protocol under which the drug was prescribed.
Why Book With London Blood Tests?
London Blood Tests provides private access to Tobramycin therapeutic drug monitoring where clinician-directed outpatient testing is appropriate.
Measures Tobramycin concentration directly - The assay provides quantitative information about circulating antibiotic levels.
Supports safe antibiotic dosing - Monitoring helps reduce the risk of excessive or inadequate drug exposure.
Relevant to kidney function - Renal clearance strongly influences Tobramycin concentrations.
Helps monitor a narrow therapeutic window - Dose timing and laboratory levels are important during aminoglycoside therapy.
Clinical details are incorporated - Dose and sample timing are essential for meaningful interpretation.
Specialist laboratory analysis - Samples undergo dedicated therapeutic-drug measurement.
Professional timed blood collection - Collection can be coordinated with the required dosing schedule.
Clear pricing - The Tobramycin Assay costs £280.
Private Tobramycin Assay Blood Test in London
London Blood Tests provides private Tobramycin Assay testing for people who require therapeutic drug monitoring under clinical supervision.
The test costs £280 and measures 1 specialist biomarker.
Results are expected approximately 3 days after laboratory receipt.
Accurate dose timing, sample timing and clinical details are essential for interpretation.